Connection

LUKASZ SZARPAK to Antidepressive Agents

This is a "connection" page, showing publications LUKASZ SZARPAK has written about Antidepressive Agents.
Connection Strength

0.201
  1. Lessons learned from the regulatory alignment in ketamine, esketamine and arketamine clinical trials: A cross-sectional analysis of protocols from ClinicalTrials.gov. Psychiatry Res. 2025 Aug; 350:116559.
    View in: PubMed
    Score: 0.201
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.